Current status of the epidemiology of heart failure

被引：11
|
作者：
Kannel W.B. [1 ]
机构：
[1] Framingham Study of the National Heart Lung and Blood Institute, Boston University, Boston, MA
来源：
Current Cardiology Reports | 1999年 / 1卷 / 1期
基金：
美国国家卫生研究院;
关键词：
Heart Failure; Left Ventricular Hypertrophy; Ventricular Hypertrophy; Coronary Disease; Valvular Heart Disease;
D O I：
10.1007/s11886-999-0035-7
中图分类号：
学科分类号：
摘要：
Epidemiologic investigation of the evolution of heart failure in the general population has provided clues to its pathogenesis, predisposing conditions, predictive modifiable risk factors, and indicators of deteriorating ventricular function. It is a major and growing problem because of the increased size of aging populations and the prolongation of the lives of cardiac patients by modern therapy. Susceptible persons must be detected early so that preventive measures can be started because the mortality rate once overt heart failure appears is unacceptably high despite recent innovations in treatment. Copyright © 1999 by Current Science Inc.
引用
收藏
页码：11 / 19
页数：8
相关论文
共 50 条
  • [1] Current Status of Inotropes in Heart Failure
    Ginwalla, Mahazarin
    Tofovic, David S.
    HEART FAILURE CLINICS, 2018, 14 (04) : 601 - +
  • [2] Current status of heart failure: global and Korea
    Park, Jin Joo
    Choi, Dong-Ju
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2020, 35 (03) : 487 - 497
  • [3] The current status of heart failure diagnostic biomarkers
    Zhang, Xi
    Schulz, Benjamin L.
    Punyadeera, Chamindie
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2016, 16 (04) : 487 - 500
  • [4] The current and future status of inotropes in heart failure management
    Arfaras-Melainis, Angelos
    Ventoulis, Ioannis
    Polyzogopoulou, Effie
    Boultadakis, Antonios
    Parissis, John
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2023, 21 (08) : 573 - 585
  • [5] Current Status of Stem Cell Therapy in Heart Failure
    Das, Anjan Kumar
    INDIAN JOURNAL OF SURGERY, 2023, 85 (SUPPL 2) : 381 - 384
  • [6] Anticoagulation in heart failure: current status and future direction
    Mihai Gheorghiade
    Muthiah Vaduganathan
    Gregg C. Fonarow
    Stephen J. Greene
    Barry H. Greenberg
    Peter P. Liu
    Barry M. Massie
    Mandeep R. Mehra
    Marco Metra
    Faiez Zannad
    John G. F. Cleland
    Dirk J. van Veldhuisen
    Ami N. Shah
    Javed Butler
    Heart Failure Reviews, 2013, 18 : 797 - 813
  • [7] Anticoagulation in heart failure: current status and future direction
    Gheorghiade, Mihai
    Vaduganathan, Muthiah
    Fonarow, Gregg C.
    Greene, Stephen J.
    Greenberg, Barry H.
    Liu, Peter P.
    Massie, Barry M.
    Mehra, Mandeep R.
    Metra, Marco
    Zannad, Faiez
    Cleland, John G. F.
    van Veldhuisen, Dirk J.
    Shah, Ami N.
    Butler, Javed
    HEART FAILURE REVIEWS, 2013, 18 (06) : 797 - 813
  • [8] Current Status of Stem Cell Therapy in Heart Failure
    Anjan Kumar Das
    Indian Journal of Surgery, 2023, 85 : 381 - 384
  • [9] Current status and problems regarding treating heart failure
    Yoo, Byung-Su
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2022, 65 (01): : 4 - 7
  • [10] The epidemiology of heart failure
    Tendera, M
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2004, 5 : S2 - S6
12345